Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...

UiPath demoing “Project Wingman” within its AI-powered automation platform at booth #400 at Ai4 2023, August 7-9 in Las Vegas The UiPath end-to-end platform uniquely combines Specialized AI solutions ...

UiPath helps companies automate tasks traditionally performed by human employees with software robots. The slower-growth ...

Continuing its evolution from a robotic process automation provider to an agentic artificial intelligence platform, UiPath Inc. today unveiled a series of new capabilities designed to simplify the ...

UiPath Inc. raised its full-year revenue outlook after cruising past Wall Street’s expectations and swinging to a profit in its latest quarterly results, powered by momentum in its artificial ...

The main goal of robotic process automation is to relieve the burden of mind-numbing, monotonous and repetitive processes. From a value perspective, an autonomous robot can help reduce staffing costs ...

UiPath Inc. (NYSE:PATH) is one of the best AI stocks to buy according to hedge funds. On June 25, UiPath announced a significant internal transformation of its Enterprise Resource Planning/ERP system.

Automation software company UiPath (NYSE:PATH) announced better-than-expected revenue in Q3 CY2025, with sales up 15.9% year on year to $411.1 million. The company expects next quarter’s revenue to be ...

UiPath offers an AI-driven automation platform, targeting workflow efficiency and accessibility for a broad range of users. PATH is undervalued, trading at a forward P/E of 22, an 11% discount to the ...

UiPath was burning cash faster than expected, and its revenue growth, though robust, was below its internal targets when the company launched a plan — dubbed Project Dawn — to slash hundreds of jobs ...